Updated:
Star Lake Bioventures
Star Lake Bioventures is a single-family office investing in biotechnology and healthcare from San Francisco and Washington, DC.
Star Lake Bioventures
Star Lake Bioventures operates as a family office that deploys capital across the biotechnology and healthcare spectrum. The firm's dual presence in Washington, DC and San Francisco, California positions it to source deals from both the policy-heavy East Coast research corridor and the venture-dense Bay Area ecosystem. The firm invests across company creation, venture-stage rounds, and growth equity within therapeutic areas including oncology, neuroscience, and rare diseases. Portfolio holdings span platforms such as gene therapy, antibody-drug conjugates, and precision diagnostics, though specific company names are not publicly disclosed. The investment team evaluates opportunities across North America and Europe. Team size and total assets under management are not publicly disclosed. The firm has maintained a low profile since its founding, with no recent hiring announcements or fund closures in the public record. No philanthropic foundation or adjacent vehicle publicly linked to Star Lake Bioventures has been identified. The firm's structural differentiator is its exclusive focus on an asset class — biotech — that requires deep scientific due diligence and long capital commitment timelines. As a single-family office, Star Lake can hold positions through clinical milestones without the redemption pressures faced by commingled biotech funds.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
Washington, DC, United States
Sector focus
Frequently asked questions
Who makes investment decisions at Star Lake Bioventures?
Investment professionals managing the firm's capital are not publicly named. The firm has no listed leadership or team profiles on any public source, and no media coverage identifies specific decision-makers.
How does Star Lake Bioventures source proprietary deal flow?
The firm leverages its co-location in San Francisco and Washington, DC to access both venture-stage biotech companies and later-stage firms interacting with regulatory agencies. No evidence of co-investor networks or formal fund-of-funds relationships exists in the public record.
Is Star Lake Bioventures a single family office or a multi-family office?
The firm operates as a single-family office, deploying capital for a single high-net-worth family. It does not manage outside limited partner capital and operates under a family office exemption from SEC registration.
What investment stages does Star Lake Bioventures typically target?
The firm invests from company creation through growth equity in therapeutic platforms, diagnostics, and healthcare technology. Stage scope spans early clinical-stage through pre-commercial, with no specified minimum check size disclosed.
Does Star Lake Bioventures participate in fund commitments or only direct deals?
The public record does not indicate whether Star Lake Bioventures makes fund commitments to external biotech venture funds or invests solely through direct deal participation. No known GP relationships or fund allocations have been reported.
Which sectors does Star Lake Bioventures explicitly avoid?
The firm's disclosed focus is limited to biotechnology, pharmaceuticals, and healthcare services. There is no public evidence of investments in digital health broadly defined, medical devices, or non-healthcare sectors.
Where does the underlying wealth come from?
The origin of the family wealth behind Star Lake Bioventures is not publicly disclosed. The firm has not attributed its capital to any named industry, technology, or commercial enterprise in any registered filings or press releases.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: